Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Aviron Aviron entered into a CRADA with the National Institute of Allergy and Infectious Diseases and a licensing agreement with
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury